Korean J Perinatol.  2010 Dec;21(4):418-423.

Urokinase Treatment of Deep Artery Thrombosis in Extremely Low Birth Weight Infant

Affiliations
  • 1Department of Pediatrics, College of Medicine, Ilsan Paik Hospital, Inje University, Ilsan, Korea. jhhwang@paik.ac.kr

Abstract

Newborns are at the highest risk for thromboembolism, although significant thromboembolic diseases are relatively rare in children and newborn. The use of central catheters seems to be the most important risk factor for vein and artery thrombosis. Additional risk factors include the properties of developing hemostatic system, hereditary, and acquired risk factors. Treatment for neonatal thromboembolism has not been established. We report a case of deep vein thrombosis that was completely treated with urokinse in extremely low birth weight infant.

Keyword

Thrombosis; Receptors; Urokinase plasminogen activator; Infant; Extremely low birth weight

MeSH Terms

Arteries
Catheters
Child
Humans
Infant
Infant, Extremely Low Birth Weight
Infant, Newborn
Risk Factors
Thromboembolism
Thrombosis
Urokinase-Type Plasminogen Activator
Veins
Venous Thrombosis
Urokinase-Type Plasminogen Activator
Full Text Links
  • KJP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr